Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 3, 2026

Nanobac Pharmaceuticals Revenue

In the year 2007, Nanobac Pharmaceuticals had annual revenue of $17.62K, down -92.17%. Nanobac Pharmaceuticals had revenue of $4.37K in the quarter ending December 31, 2007, with 86.59% growth.

Revenue
17.62K
Revenue Growth
-92.17%
P/S Ratio
0.01
Revenue / Employee
17.62K
Employees
1
Market Cap
250.00

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 200717.62K-207.47K-92.17%
Dec 31, 2006225.09K-431.72K-65.73%
Dec 31, 2005656.80K298.44K83.28%
Dec 31, 2004358.36K-124.45K-25.78%
Dec 31, 2003482.82K--
Dec 31, 2002 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Predictive Technology Group 19.17M
NanoLogix 1.27K
Q BioMed 209.29K
Alzex Neuropharma 4.73M
RegeneRx Biopharmaceuticals 76.76K
Seelos Therapeutics 2.01M
Revenue Rankings